Jerry Gurwitz to Guideline Adherence
This is a "connection" page, showing publications Jerry Gurwitz has written about Guideline Adherence.
Connection Strength
0.484
-
Tjia J, Mazor KM, Field T, Doherty P, Spenard A, Gurwitz JH. Predicting nursing home adherence to a clinical trial intervention: lessons for the conduct of cluster randomized trials. J Am Geriatr Soc. 2011 Dec; 59(12):2332-6.
Score: 0.324
-
Allen LA, Shetterly SM, Peterson PN, Gurwitz JH, Smith DH, Brand DW, Fairclough DL, Rumsfeld JS, Masoudi FA, Magid DJ. Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail. 2014 Jan; 7(1):43-50.
Score: 0.094
-
Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS. Baseline and follow-up laboratory monitoring of cardiovascular medications. Ann Pharmacother. 2011 Sep; 45(9):1077-84.
Score: 0.020
-
Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc. 2011 Aug; 59(8):1513-20.
Score: 0.020
-
Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86.
Score: 0.014
-
Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004 Jul; 10(7 Pt 2):481-6.
Score: 0.012